3-Bromo-7-(trifluoromethyl)imidazo[1,2-a]pyrimidine
97%
- Product Code: 146187
CAS:
375857-65-1
Molecular Weight: | 266.02 g./mol | Molecular Formula: | C₇H₃BrF₃N₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD08234995 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Also employed in agrochemical research for designing novel pesticides with improved metabolic stability. The bromo and trifluoromethyl groups allow further functionalization via cross-coupling reactions, making it valuable in medicinal chemistry for building complex molecules.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
50mg | 10-20 days | ฿650.00 |
+
-
|
250mg | 10-20 days | ฿970.00 |
+
-
|
1g | 10-20 days | ฿3,660.00 |
+
-
|
3-Bromo-7-(trifluoromethyl)imidazo[1,2-a]pyrimidine
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Also employed in agrochemical research for designing novel pesticides with improved metabolic stability. The bromo and trifluoromethyl groups allow further functionalization via cross-coupling reactions, making it valuable in medicinal chemistry for building complex molecules.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :